These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22978290)

  • 1. Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis.
    Verma RK; Singh AK; Mohan M; Agrawal AK; Verma PR; Gupta A; Misra A
    Mol Pharm; 2012 Nov; 9(11):3183-9. PubMed ID: 22978290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
    Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
    Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles.
    Singh AK; Abhimanyu ; Yadav AB; Sharma S; Garg R; Bose M; Misra A
    Pharmacogenomics; 2013 Apr; 14(5):531-40. PubMed ID: 23556450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis.
    Yadav AB; Muttil P; Singh AK; Verma RK; Mohan M; Agrawal AK; Verma AS; Sinha SK; Misra A
    Tuberculosis (Edinb); 2010 May; 90(3):188-96. PubMed ID: 20382085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable particles containing rapamycin for induction of autophagy in macrophages infected with Mycobacterium tuberculosis.
    Gupta A; Pant G; Mitra K; Madan J; Chourasia MK; Misra A
    Mol Pharm; 2014 Apr; 11(4):1201-7. PubMed ID: 24533458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra.
    Sharma R; Muttil P; Yadav AB; Rath SK; Bajpai VK; Mani U; Misra A
    J Antimicrob Chemother; 2007 Mar; 59(3):499-506. PubMed ID: 17242031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.
    Yadav AB; Sharma R; Muttil P; Singh AK; Verma RK; Mohan M; Patel SK; Misra A
    Indian J Exp Biol; 2009 Jun; 47(6):469-74. PubMed ID: 19634713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalable microparticles containing large payload of anti-tuberculosis drugs.
    Muttil P; Kaur J; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2007 Oct; 32(2):140-50. PubMed ID: 17681458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary Killing.
    Lawlor C; O'Connor G; O'Leary S; Gallagher PJ; Cryan SA; Keane J; O'Sullivan MP
    PLoS One; 2016; 11(2):e0149167. PubMed ID: 26894562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
    Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
    Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.
    Hirota K; Hasegawa T; Nakajima T; Inagawa H; Kohchi C; Soma G; Makino K; Terada H
    J Control Release; 2010 Mar; 142(3):339-46. PubMed ID: 19951729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.
    Shen P; Li Q; Ma J; Tian M; Hong F; Zhai X; Li J; Huang H; Shi C
    BMC Microbiol; 2017 Aug; 17(1):185. PubMed ID: 28835201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis.
    Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C
    Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin 7 Regulates Nitric Oxide Production and Apoptosis to Promote Mycobacterial Clearance in Macrophages.
    Zhang S; Liu Y; Zhou X; Ou M; Xiao G; Li F; Wang Z; Wang Z; Liu L; Zhang G
    Front Immunol; 2021; 12():779235. PubMed ID: 34925356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof].
    Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products.
    Rojas M; Barrera LF; Puzo G; Garcia LF
    J Immunol; 1997 Aug; 159(3):1352-61. PubMed ID: 9233632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex.
    Palazzo F; Giovagnoli S; Schoubben A; Blasi P; Rossi C; Ricci M
    Int J Pharm; 2013 Jan; 440(2):273-82. PubMed ID: 22659124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice.
    Sharma R; Yadav AB; Muttil P; Kajal H; Misra A
    Tuberculosis (Edinb); 2011 Jan; 91(1):107-10. PubMed ID: 21159559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.